183 related articles for article (PubMed ID: 21211087)
1. [Separate pharmaceutical budgets: skating on thin ice].
Egberts AC; de Boer A
Ned Tijdschr Geneeskd; 2010; 154(51-52):A3004. PubMed ID: 21211087
[TBL] [Abstract][Full Text] [Related]
2. The drug budget silo mentality: the Dutch case.
Koopmanschap MA; Rutten FF
Value Health; 2003; 6 Suppl 1():S46-51. PubMed ID: 12846925
[TBL] [Abstract][Full Text] [Related]
3. [Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting].
Jünger C; Rathmann W; Giani G
Dtsch Med Wochenschr; 2000 Feb; 125(5):103-9. PubMed ID: 10705882
[TBL] [Abstract][Full Text] [Related]
4. Moving beyond the drug budget silo mentality in Europe.
Drummond M; Jönsson B
Value Health; 2003; 6 Suppl 1():S74-7. PubMed ID: 12846928
[No Abstract] [Full Text] [Related]
5. The drug budget silo mentality: the French case.
Le Pen C
Value Health; 2003; 6 Suppl 1():S10-9. PubMed ID: 12846922
[TBL] [Abstract][Full Text] [Related]
6. [Incentives for especially cost effective prescribing. The physician protects his budget, the patient saves co-pay].
Schmidt K
MMW Fortschr Med; 2006 Nov; 148(44):57, 59. PubMed ID: 17619443
[No Abstract] [Full Text] [Related]
7. Fixed budgets as a cost containment measure for pharmaceuticals.
Granlund D; Rudholm N; Wikström M
Eur J Health Econ; 2006 Mar; 7(1):37-45. PubMed ID: 16435117
[TBL] [Abstract][Full Text] [Related]
8. Sustainable health care for Canada.
Maxwell J; Angus D; Albert T
Leadersh Health Serv; 1995; 4(1):27-31. PubMed ID: 10140965
[TBL] [Abstract][Full Text] [Related]
9. The drug budget silo mentality in Europe: an overview.
Garrison L; Towse A
Value Health; 2003; 6 Suppl 1():S1-9. PubMed ID: 12846921
[No Abstract] [Full Text] [Related]
10. [The budget control function of the Drug Reimbursement System].
Pronk MH; Bonsel GJ; van der Kuy A
Ned Tijdschr Geneeskd; 2002 Sep; 146(37):1729-33. PubMed ID: 12357873
[TBL] [Abstract][Full Text] [Related]
11. Dialogue. Prescription for problems? Capitating mental health drugs--the great debate.
Docherty JP; Browne RA; Farmer M
Behav Healthc Tomorrow; 1998 Oct; 7(5):32-8. PubMed ID: 10185199
[TBL] [Abstract][Full Text] [Related]
12. The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation.
Lamers LM; van Vliet RC
Health Policy; 2004 Apr; 68(1):113-21. PubMed ID: 15033558
[TBL] [Abstract][Full Text] [Related]
13. [Pharmaceutical organization recommends to budget-concerned physicians: simply do without some prescriptions!].
Vorderwulbecke U
MMW Fortschr Med; 1999 Dec; 141(48):56. PubMed ID: 10766549
[No Abstract] [Full Text] [Related]
14. [The budget control function of the Drug Reimbursement System].
Vooren PH
Ned Tijdschr Geneeskd; 2002 Nov; 146(47):2264-5. PubMed ID: 12481525
[No Abstract] [Full Text] [Related]
15. Using disease management and market reforms to address the adverse economic effects of drug budgets and price and reimbursement regulations in Germany.
Schwermann T; Greiner W; v d Schulenburg JM
Value Health; 2003; 6 Suppl 1():S20-30. PubMed ID: 12846923
[TBL] [Abstract][Full Text] [Related]
16. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.
Godman B; Wettermark B; Hoffmann M; Andersson K; Haycox A; Gustafsson LL
Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):65-83. PubMed ID: 19371180
[TBL] [Abstract][Full Text] [Related]
17. [Drug prescribing in primary health care for diabetic and non-diabetic patients: effect of therapeutic drug budgeting].
Jünger C; Rathmann W; Giani G
Gesundheitswesen; 1999 Dec; 61(12):607-13. PubMed ID: 10666939
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical management strategies of industrialized countries.
Brier KL
Formulary; 1995 Oct; 30(10):606-10, 614. PubMed ID: 10151724
[TBL] [Abstract][Full Text] [Related]
19. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
Openshaw MS
Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
[TBL] [Abstract][Full Text] [Related]
20. Spending on pharmaceuticals in Italy: macro constraints with local autonomy.
Mapelli V; Lucioni C
Value Health; 2003; 6 Suppl 1():S31-45. PubMed ID: 12846924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
